Karger Publishers http://content.karger.com Last 20 articles published by Karger en Copyright 2010, S.Karger AG Wed, 08 Sep 2010 19:06:51 +0100 S.Karger AG http://content.karger.com/company/help.asp 20 Does Sensitization to Foods in Adults Occur Always in the Gut?http://content.karger.com/produktedb/produkte.asp?doi=319203 http://content.karger.com/produktedb/produkte.asp?doi=319203 Sun, 24 Jul 2011 00:00:00 +0100 Int Arch Allergy Immunol 2011;154:6–14 (DOI:10.1159/000319203) Cardiovascular Disease in Cushing’s Syndrome: Heart versus Vasculaturehttp://content.karger.com/produktedb/produkte.asp?doi=318566 http://content.karger.com/produktedb/produkte.asp?doi=318566 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):50–54 (DOI:10.1159/000318566) Medical Treatment in Cushing’s Syndrome: Dopamine Agonists and Cabergolinehttp://content.karger.com/produktedb/produkte.asp?doi=317716 http://content.karger.com/produktedb/produkte.asp?doi=317716 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):116–119 (DOI:10.1159/000317716) Mortality in Cushing’s Diseasehttp://content.karger.com/produktedb/produkte.asp?doi=315813 http://content.karger.com/produktedb/produkte.asp?doi=315813 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):71–76 (DOI:10.1159/000315813) Medical Treatment of Cushing’s Disease: Somatostatin Analogues and Pasireotidehttp://content.karger.com/produktedb/produkte.asp?doi=314352 http://content.karger.com/produktedb/produkte.asp?doi=314352 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):120–124 (DOI:10.1159/000314352) Coagulopathy in Cushing’s Syndromehttp://content.karger.com/produktedb/produkte.asp?doi=314349 http://content.karger.com/produktedb/produkte.asp?doi=314349 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):55–59 (DOI:10.1159/000314349) Pathophysiology of Diabetes Mellitus in Cushing’s Syndromehttp://content.karger.com/produktedb/produkte.asp?doi=314319 http://content.karger.com/produktedb/produkte.asp?doi=314319 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):77–81 (DOI:10.1159/000314319) Neuropsychiatric Disorders in Cushing’s Syndromehttp://content.karger.com/produktedb/produkte.asp?doi=314317 http://content.karger.com/produktedb/produkte.asp?doi=314317 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):65–70 (DOI:10.1159/000314317) Management of Diabetes Mellitus in Cushing’s Syndromehttp://content.karger.com/produktedb/produkte.asp?doi=314316 http://content.karger.com/produktedb/produkte.asp?doi=314316 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):82–85 (DOI:10.1159/000314316) Hypertension in Cushing’s Syndrome: From Pathogenesis to Treatmenthttp://content.karger.com/produktedb/produkte.asp?doi=314315 http://content.karger.com/produktedb/produkte.asp?doi=314315 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):44–49 (DOI:10.1159/000314315) Role of the PPAR-γ System in Normal and Tumoral Pituitary Corticotropic Cells and Adrenal Cellshttp://content.karger.com/produktedb/produkte.asp?doi=314312 http://content.karger.com/produktedb/produkte.asp?doi=314312 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):23–27 (DOI:10.1159/000314312) Pituitary Radiotherapy for Cushing’s Diseasehttp://content.karger.com/produktedb/produkte.asp?doi=314299 http://content.karger.com/produktedb/produkte.asp?doi=314299 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):107–110 (DOI:10.1159/000314299) Skeletal Diseases in Cushing’s Syndrome: Osteoporosis versus Arthropathyhttp://content.karger.com/produktedb/produkte.asp?doi=314298 http://content.karger.com/produktedb/produkte.asp?doi=314298 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):60–64 (DOI:10.1159/000314298) Epidemiology of Cushing’s Syndromehttp://content.karger.com/produktedb/produkte.asp?doi=314297 http://content.karger.com/produktedb/produkte.asp?doi=314297 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):1–5 (DOI:10.1159/000314297) Role of Somatostatin Receptors in Normal and Tumoral Pituitary Corticotropic Cellshttp://content.karger.com/produktedb/produkte.asp?doi=314296 http://content.karger.com/produktedb/produkte.asp?doi=314296 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):11–16 (DOI:10.1159/000314296) Novel Insights in the Diagnosis of Cushing’s Syndromehttp://content.karger.com/produktedb/produkte.asp?doi=314295 http://content.karger.com/produktedb/produkte.asp?doi=314295 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):35–43 (DOI:10.1159/000314295) Management of Dyslipidemia in Cushing’s Syndromehttp://content.karger.com/produktedb/produkte.asp?doi=314294 http://content.karger.com/produktedb/produkte.asp?doi=314294 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):91–95 (DOI:10.1159/000314294) Role of Dopamine Receptors in Normal and Tumoral Pituitary Corticotropic Cells and Adrenal Cellshttp://content.karger.com/produktedb/produkte.asp?doi=314293 http://content.karger.com/produktedb/produkte.asp?doi=314293 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):17–22 (DOI:10.1159/000314293) Medical Treatment of Cushing’s Syndrome: Adrenal-Blocking Drugs and Ketaconazolehttp://content.karger.com/produktedb/produkte.asp?doi=314292 http://content.karger.com/produktedb/produkte.asp?doi=314292 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):111–115 (DOI:10.1159/000314292) Role of the mTOR Pathway in Normal and Tumoral Adrenal Cellshttp://content.karger.com/produktedb/produkte.asp?doi=314280 http://content.karger.com/produktedb/produkte.asp?doi=314280 Fri, 10 Sep 2010 00:00:00 +0100 Neuroendocrinology 2010;92(suppl 1):28–34 (DOI:10.1159/000314280)